Miskowiak KW, Kjærstad HL, Vieta E, Yatham LN. Cognitive Function in Bipolar Disorder - Latest Insights, Key Challenges, and New Frontiers. Nature Mental Health. 2026 (in press).

Jespersen AE, Lumbye A, Vinberg M, Glenthøj LB, Nordentoft M, Bruun CF, Bülow C, Makransky G, Wæhrens E, Miskowiak KW. Virtual Reality-Based Cognitive Remediation in Mood and Psychosis Spectrum Disorders: Effects of a Randomised, Controlled, Double-blind Trial. Lancet Digital Health 2026 (in press).

Zarp J, Kjaerstad HL, Iversen AE, Bjertrup AJ, Rasmussen KHE, Fares-Otero NE, De Prisco M, Vieta E, Vinberg M, Kessing LV, Miskowiak KW. Childhood maltreatment and impaired emotion regulation and processing in remitted affective disorders: Evidence from a large-scale investigation​. J Affect Disord. 2026;393(Pt B):120405.​

Van Rheenen TE, Lewandowski KE, Pinkham A, Varo C, Caruana G, Gruber J, Zarp J, Young AH, Yatham LN, Vieta E, Torres IJ, Tsapekos D, Sumiyoshi T, Stokes PRA, Schaffer A, Purdon S, Porter RJ, McIntyre RS, Martinez-Aran A, Lopez-Jaramillo C, Lafer B, Kessing LV, Kjaerstad HL, Hasler G, Gallagher P, Douglas K, Dols A, Carvalho AF, Burdick KE, Bowie CR, Bonnin CM, Balanza-Martinez V, Miskowiak KW. Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study. Bipolar Disord. 2026;28(2):e70083.

Tsapekos D, Kalfas M, Schandorff JM, Del Mar Bonnin C, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Kessing LV, Kjaerstad HL, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Zarp J, Young AH, Vieta E, Miskowiak KW. Predicting Response to Pro-Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force. Acta Psychiatr Scand. 2026;153(5):374-401.

Segerlin SV, Damgaard V, Jespersen AE, Schandorff JM, Thommesen KK, Sankar A, Fisher PM, Macoveanu J, Miskowiak KW. Neural underpinnings of verbal memory encoding and recognition impairments in individuals with clinically stable mood or schizophrenia spectrum disorders. Psychiatry Res Neuroimaging. 2026;360:112221.​

Schandorff JM, Zarp J, Bjertrup AJ, Kjaerstad HL, Jespersen AE, Damgaard V, Vinberg M, Knorr U, Kessing LV, Miskowiak KW. Cognitive Complaints in Bipolar Disorder: Relation to Estimated Illness-Related Objective Cognitive Decline, Functioning, and Quality of Life​. Bipolar Disord. 2026;28(2):e70095.

Schandorff JM, Eggers MB, Zarp J, Nordseth BOB, Hansen L, Kessing LV, Miskowiak KW. Cognitive impairments in a clinical sample of recently diagnosed outpatients with bipolar disorder: The role of lifestyle, comorbidities, and psychotropic medications. J Affect Disord. 2026;399:121038.

Montejo L, Schandorff JM, Zarp J, Kjaerstad HL, Jespersen AE, Bort M, Ruiz A, Sole B, Torrent C, Martinez-Aran A, Vieta E, Miskowiak KW. Mind the gap: The impact of discrepancy between current cognitive function and premorbid intelligence on psychosocial functioning in older age bipolar disorder. J Affect Disord. 2026;392:120094.​

Miskowiak KW, Ozenne B, Kjaerstad HL, Fisher PM, Beaman EE, Dam VH, Ysbaek-Nielsen AT, Knudsen GM, Kessing LV, Macoveanu J, Frokjaer VG, Sankar A. Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders. Neuropsychopharmacology. 2026;51(3):604-11.

Miskowiak KW, Burdick KE. Cognition in Psychiatry: Treatment Targets, Mechanisms, and Assessment Innovations. Acta Psychiatr Scand. 2026;153(5):311-4.

Miskowiak K, Kjaerstad HL, Lystlund S, Sankar A, Kessing L, Vinberg M. Associations Between Cognitive Functions and Subsequent Mood Disorder Prognosis in Low-Risk, High-Risk and Affected Monozygotic Twins: A Seven-Year Follow-Up Study. Acta Psychiatr Scand. 2026;153(5):432-48.​

Macoveanu J, Kjaerstad HL, Sankar A, Siebner HR, Kessing LV, Vinberg M, Miskowiak K. Fronto-limbic emotional-processing markers signal risk of onset rather than risk of recurrence in mood disorders: Evidence from a longitudinal twin study. Psychiatry Clin Neurosci. 2026;80(4):328-36.

Lewandowski KE, Luo J, Kolstad J, Chang K, Lumbye A, Jespersen AE, Miskowiak KW. Cognition Assessment in Virtual Reality (CAVIR)-English Version: Validation of a Novel Virtual Reality Test for Daily Life Cognitive Functions in Patients With Affective Disorders. Acta Psychiatr Scand. 2026;153(5):544-52.

Kjaerstad HL, Segerlin SV, Macoveanu J, Coello K, Stanislaus S, Munkholm K, Faurholt-Jepsen M, Dam VH, Vinberg M, Kessing LV, Miskowiak KW. Neural correlates of cognitive improvement over time in patients newly diagnosed with bipolar disorder. Neurosci Appl. 2026;5:107008.​

Kjaerstad HL, Nordseth BOB, Vinberg M, Kessing LV, Miskowiak KW. Characterizing high cognitive performance in persons with mood disorders and their unaffected relatives: associations with emotional cognition, functioning, and clinical outcomes. Int J Bipolar Disord. 2026;14(1).

Kjaerstad HL, Iversen AE, Vinberg M, Kessing LV, Zarp J, Miskowiak KW. Exploring the Associations Between Affective and Non-Affective Cognitive Domains in Mood Disorders and Healthy Controls Using Network Analysis​. Acta Psychiatr Scand. 2026;153(5):534-43.

Jespersen AE, Lumbye A, Vinberg M, Glenthoj LB, Nordentoft M, Bruun CF, von Bulow C, Makransky G, Waehrens EE, Miskowiak KW. Virtual reality-based cognitive remediation versus virtual reality control in people with mood or psychosis spectrum disorders in Denmark: a single-centre, double-blind, randomised controlled trial. Lancet Digit Health. 2026:101002.

Jespersen AE, Lindhardsen JM, Lumbye A, Damgaard V, Schandorff JM, Mikkelsen C, Didriksen M, Ostrowski SR, Kessing LV, Miskowiak KW. Virtual reality-based cognitive screening in psychiatry: Investigating optimal cut-offs for cognitive impairment in bipolar disorder. Neurosci Appl. 2026;5:106880.

Jensen KHR, Ostergaard IP, Damgaard V, Schandorff JM, Macoveanu J, Pernet C, Julsgart HW, Johansen A, Brendstrup-Brix K, Kessing LV, Jorgensen MB, Ehrenreich H, Knudsen GM, Miskowiak K. Prefrontal and hippocampal microstructural gray matter following cognitive training under moderate hypoxia in mood disorders: a randomized controlled trial. Front Neurosci. 2026;20:1798024.

Fares-Otero NE, Sole B, Jespersen AE, Roberto-Herrero N, Martin-Parra S, Lopez-Escribano R, Perez-Ramos A, Piazza F, Ruiz-Munoz A, Varo C, Lumbye AM, Vieta E, Martinez-Aran A, Miskowiak KW. Cognition Assessment in Virtual Reality (CAVIR)-Spanish Version: Validation of a Novel Virtual Reality Test for Daily-Life Cognitive Skills in Bipolar Disorder​. Bipolar Disord. 2026;28(4):e70118.​

Zarp J, Kjaerstad HL, Porten MN, Kessing LV, Miskowiak KW. Disentangling Subjective Sleep and Objective Cognition: Insights From Two Independent Cross-Sectional Cohorts of Remitted Bipolar Disorder​. Bipolar Disord. 2025;27(6):435-48.​

Kjaerstad HL, Macoveanu J, Ysbaek-Nielsen AT, Damgaard V, Frangou S, Knudsen GM, Coello K, Stanislaus S, Faurholt-Jepsen M, Vinberg M, Kessing LV, Miskowiak KW. Longitudinal Trajectory of Cognition, Brain Morphometry, and Brain Predicted Age in Unaffected First-Degree Relatives of Patients With Bipolar Disorder. Bipolar Disord. 2025;27(6):424-34.

Jespersen A, Lachmann R, Nordseth B, Sivesgaard J, Christiansen L, Miskowiak KW. Investigation of the feasibility and efficacy of a fully immersive virtual reality-based memory training paradigm on memory performance in healthy controls and patients with mood or schizophrenia spectrum disorders. Nord J Psychiatry. 2025;79(8):642-50.​

Zarp J, Bruun CF, Christiansen ST, Krogh HB, Kuchinke OV, Bernsen CL, Jespersen AE, Bardram JE, Kessing LV, Miskowiak KW. Web-based cognitive screening in bipolar disorder: validation of the Internet-based Cognitive Assessment Tool in remote administration settings​. Nord J Psychiatry. 2025;79(1):52-61.​

Schandorff JM, Madsen ABF, Damgaard V, Little B, Sankar A, Macoveanu J, Frokjaer VG, Kessing LV, Jorgensen MB, Knudsen GM, Gallagher P, Miskowiak KW. Multivariate associations between structural brain changes and cognitive impairment in partially or fully remitted persons with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2025;140:111425.

Miskowiak KW, Bjerregaard SM, Fink-Jensen A, Kessing LV, Damgaard V, Schandorff JM, Kjaerstad HL, Macoveanu J, Frokjaer VG, Knudsen GM, Sankar A. Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders​. J Affect Disord. 2025:119841.

Macoveanu J, Zarp J, Vinberg M, Brendstrup-Brix K, Kessing LV, Jorgensen MB, Miskowiak KW. Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial​. J Psychopharmacol. 2025;39(2):164-70.

Kjaerstad HL, Jespersen AE, Bech JL, Weidemann S, Bjertrup AJ, Jacobsen EH, Simonsen S, Glenthoj LB, Nordentoft M, Reveles K, Wobbe T, Lopes M, Lyngholm D, Miskowiak KW. Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality​. Eur Neuropsychopharmacol. 2025;92:1-9.

Hestbaek E, Pedersen JK, Kjaerstad HL, Grage KR, Kessing LV, Simonsen S, Miskowiak K. Emotional cognition in patients with borderline personality disorder and patients with bipolar disorder type II: Evidence for transdiagnostic and differential diagnostic differences? Eur Neuropsychopharmacol. 2025;98:13-21.

Fares-Otero NE, Miskowiak KW. Social belief updating in bipolar disorder and childhood maltreatment: A novel direction for research and clini​cal practice. Eur Neuropsychopharmacol. 2025;97:5-7.

Damgaard V, Schandorff JM, Macoveanu J, Sankar A, Zarp J, Fisher PM, Jorgensen MB, Kessing LV, Knudsen GM, Frokjaer VG, Miskowiak KW. Network-wide aberrancies in neuronal activity during working memory in a large cohort of patients with mood disorders: associations with cognitive impairment and functional disability​. Mol Psychiatry. 2025.

Bjertrup AJ, Andreu H, Macoveanu J, Sankar A, Moszkowicz M, Nielsen RE, Pagsberg AK, Vieta E, Kessing LV, Miskowiak KW. Reduced prefrontal response to fearful faces in recent mothers with bipolar disorder and its association with mother-infant interaction and infant development​. Psychiatry Res. 2025;351:116610.

Miskowiak KW, Macoveanu J, Ozenne B, Beaman EE, Dam VH, Fisher PM, Knudsen GM, Kessing LV, Jørgensen MB, Frokjaer VG, Sankar A. Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders. Acta Psychiatr Scand. 2025.

Kjærstad HL, Ritsma F, Coello K, Stanislaus S, Munkholm K, Faurholt-Jepsen M, Macoveanu J, Bjertrup AJ, Vinberg M, Kessing LV, Miskowiak KW. Neural subgroups in unaffected first-degree relatives of patients with bipolar disorder during emotion regulation. Psychol Med. 2025;55:e45.​

Jespersen AE, Lumbye A, Schandorff J, Damgaard V, Glenthoj LB, Nordentoft M, Mikkelsen C, Didriksen M, Ostrowski SR, Vinberg M, Waehrens EE, Miskowiak KW. Cognition Assessment in Virtual Reality (CAVIR): Associations with neuropsychological performance and activities of daily living in patients with mood or psychosis spectrum disorders. J Affect Disord. 2025;369:1053-63.​

Damgaard V, Fortea L, Schandorff JM, Macoveanu J, Little B, Gallagher P, Knudsen GM, Kessing LV, Miskowiak KW. Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder. Neuropsychopharmacology. 2025.​

​Bjertrup AJ, Rasmussen KHE, Miskowiak KW. Psychological prevention of postpartum depression for expectant parents. J Affect Disord. 2025;378:58-73.​

Vinberg M, Sperling JD, Frikke-Schmidt R, Scheike T, Kessing LV, Miskowiak K. Lifestyle factors, metabolic syndrome and apolipoprotein E in monozygotic twins with, at risk of and without affective disorders, as predictors of onset or recurrence of affective episodes, a seven-years follow-up study. J Psychosom Res. 2025;197:112378.​

Fortea L, Ysbaek-Nielsen AT, Zarp J, Fisher PM, Kessing L, Jorgensen MB, Knudsen GM, Radua J, Vieta E, Macoveanu J, Miskowiak KW. Functional connectivity differences in patients with mood disorders: an exploratory fMRI study comparing electroconvulsive therapy with pharmacological treatment. Neurosci Appl. 2025;4:105522.​

Bjertrup A, Macoveanu J, Miskowiak K. Neurocognitive response to fearful faces in mothers​. Behav Brain Res. 2025;495:115766.

​Thommesen KK, Damgaard V, Mariegaard J, Jespersen AE, Ysbaek-Nielsen AT, Mikkelsen C, Didriksen M, Ostrowski SR, Jorgensen MB, Macoveanu J, Miskowiak KW. Neural underpinnings of memory encoding and retrieval: Validation of a novel ecologically valid fMRI paradigm. Neurosci Appl. 2024;3:104084.

Petersen JZ, Macoveanu J, Ysbaek-Nielsen AT, Kessing LV, Jorgensen MB, Miskowiak KW Neural correlates of episodic memory decline following electroconvulsive therapy: An exploratory functional magnetic resonance imaging study J Psychopharmacol. 2024;38(2):168-77.​

Miskowiak KW, Roikjer TK, Mariegaard J, Bech JL, Obel ZK, Vejstrup B, Hansen L, Kessing LV Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic Eur Neuropsychopharmacol. 2024;84:27-34.​

Miskowiak KW, Petersen JZ, Macoveanu J, Ysbaek-Nielsen AT, Lindegaard IA, Cramer K, Mogensen MB, Hammershoj LG, Stougaard ME, Jorgensen JL, Schmidt LS, Vinberg M, Ehrenreich H, Hageman I, Videbech P, Gbyl K, Kellner CH, Kessing LV, Jorgensen MB Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial Eur Neuropsychopharmacol. 2024;79:38-48.

Miskowiak KW, Obel ZK, Guglielmo R, Bonnin CDM, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Kessing LV, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Hasler G Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force Bipolar Disord. 2024;26(3):216-39.​

Miskowiak KW, Kjaerstad HL Can cognition screening in the clinic aid personalised treatment in bipolar disorder? Eur Neuropsychopharmacol. 2024;81:10-1.​

Miskowiak KW, Damgaard V, Schandorff JM, Macoveanu J, Knudsen GM, Johansen A, Plaven-Sigray P, Svarer C, Fussing CB, Cramer K, Jørgensen MB, Kessing LV, Ehrenreich H Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial Trials. 2024;25(1):648.​

Macoveanu J, Zarp Petersen J, Mariegaard J, Elleby Jespersen A, Cramer K, Fussing Bruun C, Østergaard Madsen H, Balslev Jørgensen Dmsc M, Vinberg Dmsc M, Fisher PM, Moos Knudsen G, Hageman I, Ehrenreich Dmsc H, Vedel Kessing Dmsc L, Woznica Miskowiak Dmsc K Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial Running title: Treatment of cognitive impairment 2024.​

Macoveanu J, Kjaerstad HL, Halvorsen KS, Fisher PM, Vinberg M, Kessing LV, Miskowiak KW Trajectory of reward-related abnormalities in unaffected relatives of patients with bipolar disorder – A longitudinal fMRI study J Psychiatr Res. 2024;170:217-24.​

Macoveanu J, Fortea L, Kjaerstad HL, Coello K, Faurholt-Jepsen M, Fisher PM, Knudsen GM, Radua J, Vieta E, Frangou S, Vinberg M, Kessing LV, Miskowiak KW Longitudinal changes in resting-state functional connectivity as markers of vulnerability or resilience in first-degree relatives of patients with bipolar disorder Psychol Med. 2024:1-9.​

Macoveanu J, Craciun S, Ketterer-Sykes EB, Ysbæk-Nielsen AT, Zarp J, Kessing LV, Jørgensen MB, Miskowiak KW. Amygdala and hippocampal substructure volumes and their association with improvement in mood symptoms in patients with mood disorders undergoing electroconvulsive therapy. Psychiatry Res Neuroimaging. 2024;343:111859.​

​Kjaerstad HL, de Siqueira Rotenberg L, Macoveanu J, Coello K, Faurholt-Jepsen M, Bjertrup AJ, Knudsen GM, Fisher PM, Vinberg M, Kessing LV, Lafer B, Miskowiak KW Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI study Bipolar Disord. 2024.​

Jespersen AE, Obel Z, Lumbye A, Kessing LV, Miskowiak KW Bipolar-ADHD comorbidity: screening for differences in neurocognition and virtual reality-based cognitive performance Nord J Psychiatry. 2024;78(3):238-46.

Jespersen AE, Lumbye A, Vinberg M, Glenthoj L, Nordentoft M, Waehrens EE, Knudsen GM, Makransky G, Miskowiak KW Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial Trials. 2024;25(1):82.​

Bjertrup AJ, Kofoed J, Egmose I, Wendelboe K, Southgate V, Vaever MS, Miskowiak KW Prenatal affective cognitive training to reduce the risk of postpartum depression (PACT): study protocol for a randomized controlled trial Trials. 2024;25(1):478.​

Fortea L, Ysbæk-Nielsen AT, Macoveanu J, Petersen JZ, Fisher PM, Kessing LV, Knudsen GM, Radua J, Vieta E, Miskowiak KW​  Aberrant resting-state functional connectivity underlies cognitive and functional impairments in remitted patients with bipolar disorder   Acta Psychiatr Scand 1-13​​​

Miskowiak, KW;​​ Kjærstad, HL; Lemvigh, CK; Ambrosen, KS; Thorvald, MS; Kessing, LV; Glenthoj, BY; Ebdrup, BH; Fagerlund, B Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis J Psychiatr Res, 2023 vol. 163 pp. 278-287   

Macoveanu J, Petersen JZ, Fisher PM, Kessing LV, Knudsen GM, Miskowiak KW Associations between aberrant working memory-related neural activity and cognitive impairments in somatically healthy, remitted patients with mood disorders​  Psychol Med. 2023 1-11   ​

​Rotenberg LS*, Kjærstad HL*, Varo C, Vinberg M, Kessing LV, Lafer B, Miskowiak KW The longitudinal trajectory of emotional cognition in subgroups of recently diagnosed patients with bipolar disorder​ Eur. Neuropsyhopharmacol. 2023, 71:9-24 *Contributed equally as first authors

Jespersen AE, Røen I, Lumby A, Nordentoft M, Glenthøj LB, Miskowiak KW Feasibility and effect of an immersive virtual reality-based platform for cognitive training in real-life scenarios in patients with mood - or psychotic disorders: A randomized, controlled proof-of-concept study  Neuroscience Applied 2023, 101120​

Ehrenreich H, Gassmann M, Poustka L, Burtscher M, Hammermann P, Sirén A, Nave K, Miskowiak K ​Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress Neuroprotection 2023, 1-11

Miskowiak KW, Bech JL, Henriksen AC, Johnsen S, Podlekareva D, Marner L    Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients ​ Brain Sci. 2022, 13(1):23​

Macoveau J, Damgaard V, Ysbæk-Nielsen AT, Frangou S, Yatham LN, Chakrabarty T, Stougaard ME, Knudsen GM, Vinberg M, Kessing LV, Kjaerstad HL, Miskowiak KW Early longitudinal changes in brain structure and cognitive functioning in remitted patients with recently diagnosed bipolar disorder​ J Affect Disord. 2023, 339:153-161   

Kjærstad HL, Haldorsen T, Vinberg M, Kessing LV, Miskowiak KW ​Associations between emotional and non-emotional cognition and subsequent mood episodes in recently diagnosed patients with bipolar disorder  J Affect Disorders 2022, 324: 16-23   ​

Miskowiak KW, Pedersen JK, Gunnarsson DV, Roikjer TK, Podlekareva D, Hansen H, Dall CH, Johnsen S Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life J Affect Disord. 2022 Dec 28;324:162-169. doi: 10.1016/j.jad.2022.12.122. 

Kjærstad HL, Søhol K, Vinberg M, Kessing LV, Miskowiak KW The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study  Eur Neurop. 2022 Nov 30;67:4-21. doi: 10.1016/j.euroneuro.2022.11.004. 

Macoveanu J, Stougaard ME, Kjærstad HL, Knudsen GM, Vinberg M, Kessing LV, Miskowiak KW Trajectory of aberrant reward processing in patients with bipolar disorder - A longitudinal fMRI study  J Affect Disord. 2022 Sep 1;312:235-244. doi: 10.1016/j.jad.2022.06.053. Epub 2022 Jun 26

Kjærstad HL, Hellum KS, Haslum NH, Lopes MN, Noer TZ, Kessing LV, Miskowiak KW Assessment of the validity and feasibility of a novel virtual reality test of emotion regulation in patients with bipolar disorder and their unaffected relatives​  J Affect Disord. 2022 Sep 8;S0165-0327(22)00999-5. doi: 10.1016/j.jad.2022.09.004. 

​​Miskowiak KW, Seeberg I, Jensen MB, Balanza-Martinez V, Bonnin  CDM, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes P, Sumiyoshi T, Torres IJ, Rheenen TEV, Yatham LN, Young AH, Kessing LV, Burdick KE, Vieta E Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force Bipolar Disord. 2022 Jun;24(4):354-374. doi.10.1111/bdi.13193. Epub 2022 Feb 24

M​iskowiak KW, Yalin N, Seeberg I, Burdick KE, Balanzá-Martínez V, Bonnin CDM, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Kessing LV, Lafer B, Lewandowski KE, López-Jaramillo C, Martines-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Sumiyoshi T, Torres IJ, Rheenen TEV, Yatham LN, Young AH, Vieta E, Stokes PRA Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force​ Bipolar disord. 2022 Aug 11., 24(6): 615-636. doi: 10.1111/bdi.13247. 

​Kjærstad HL, Rotenberg LdS, Knudsen GM, Vinberg M, Kessing LV, Macoveanu J, Lafer B, Miskowiak KW  The longitudinal trajectory of emotion regulation and associated neural activity in patients with bipolar disorder: A prospective fMRI study​ Acta Pschiatr Scand. 2022 Aug 14, 146(6): 568-582. doi: 10.1111/acps.13488. 

Kjærstad HL, Poulsen E, Vinberg M, Kessing LV, Miskowiak KW Differential trajectory of cognitive functions in neurocognitive subgroups of newly diagnosed patients with bipolar disorder and their unaffected first-degree relatives - A longitudinal study J Affect Disord. 2022 Aug 15;311:115-125. doi: 10.1016/j.jad.2022.05.045. Epub 2022 May 14  

​Kjærstad HL, Damgaard V, Knudsen GM, Vinberg M, Kessing LV, Macoveanu J, Miskowiak KW Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder    Eur Neuroph. 2022 May 9;60:7-18. doi 10.1016/j.euroneuro.2022.04.010​​​​​

Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, Rungby J, Porsberg CM, Johnsen S Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications  Eur Neuroph. 2022 Apr 14;59:82-92. doi: 0.1016/j.euroneuro.2022.04.004

Nielsen SL, Ludwigsen T, Johnsen S, Miskowiak KW [Cognitive late sequelae of COVID-19]​Ugeskr Laeger. 2022 Apr 11: 184(15):V09210730. Article in Danish​

Hørlyck LD, Jespersen AE, King JA, Ullum H, Miskowiak KW, Impaired allocentric spatial memory in patients with affective disorders  J Psychiartr Res, 2022 vol. 150 pp. 153-159​​​

Mogensen MB, Macoveanu J, Knudsen GM, Ott CV, Miskowiak KW Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder    Eur Neuropsychopharmacol. 2022 Mar;56: 50-59. doi: 10.1016/ j.euroneuro.2021.11.010. Epub 2021 Dec 20

Hammershøj LG, Petersen JZ, Jensen HM, Jørgensen MB, Miskowiak KW Cognitive Adverse Effects of Electroconvulsive Therapy: A Discrepancy Between Subjective and Objective Measures? ​ J ECT. 2022 Mar 1; 38(1): 30-38. doi: 10.1097

Miskowiak, KW; Seeberg, I; Jensen, MB; Balanzá-Martínez, V; Del Mar Bonnin, C; Bowie, CR; Carvalho, AF; Dols, A; Douglas, K; Gallagher, P; Hasler, G; Lafer, B; Lewandowski, KE; López-Jaramillo, C; Martinez-Aran, A; McIntyre, RS; Porter, RJ; Purdon, SE; Schaffer, A; Stokes, P; Sumiyoshi, T; Torres, IJ; Van Rheenen, TE; Yatham, LN; Young, AH; Kessing, LV; Burdick, KE; Vieta, E​​​​ Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force ​Bipolar Disord.  24(4): 354-374. 2022 Feb 16. doi: 10.1111/bdi.13193.

​​Petersen JZ, Varo C, Skovsen CF, Ott CV, Kjaerstad HL, Vieta E, Harmer CJ, Knudsen GM, Kessing LV, Macoveanu J, Miskowiak K Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study  Bipolar disord. 2022 Feb. doi: 10.1111/bdi. 13100. Epub 2021 Jun 18​​

​Miskowiak KW, Mariegaard J, Jahn FS, Kjærstad HL Associations between cognition and subsequent mood episodes in patients with bipolar disorder and their unaffected relatives: A systematic review​  J Affect Disord. 2022 Jan 15;297:176-188.doi: 10.1016/j.jad.2021.10.044. Epub 2021 Oct 24.​

Macoveanu J, Damgaard V, Ott CV, Knudsen, Kessing LV, Miskowiak KW Action-based cognitive remediation in bipolar disorder improved verbal memory but had no effect on the neural response during episodic memory encoding​ Psychiatry Res Neuroimaging 2022 Jan;319:111418. doi: 10.1016/j.pscychresns. 2021.111418. Epub 2021 Nov 23.​​

Bjertrup A, Macoveanu J, Laurent H, Moszkowicz M, Finnegan MK, Egmose I, Fisher P MD, Nielsen RE, Pagsberg AK, Kessing LV, Væver M, Miskowiak K Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder​ Eur Neuropsychopharmacol. 2022 Jan; 54:720.doi: 10.1016/j.euroneuro.2021.09.011. Epub 2021 Oct 24.​​

​​Miskowiak, KW; Jespersen, AE; Kessing, LV; Aggestrup, AS; Glenthøj, LB; Nordentoft, M; Ott, CV; Lumbye, A Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders  ​​J Psychiatr Res, 2021 vol. 145 pp.​​ 182-189​

Macoveau J, Damgaard V, Ott Caroline V, Knudsen Gitte M, Kessing Lars V, Miskowiak Kamilla W Action-based cognitive remediation in bipolar disorder improved verbal memory but had no effect on the neural response during episodic memory encoding ​​​ Neuroimaging, 2022-01-01, Volume 319, Article 111418​​​​​​​

Macoveanu J, Freeman KO, Kjærstad HL, Knudsen GM, Kessing LV, Miskowiak KW Structural brain abnormalities associated with cognitive impairments in bipolar disorder Acta Psychiatr Scand. 2021;00:1–13

Varo C , Kjærstad HL, Poulsen E, Meluken I, Vieta E, Kessing LV, Maj Vinberg M , Miskowiak KW Emotional cognition subgroups in mood disorders: Associations with familial risk j.euroneuro.2021.05.003

Miskowiak, KW; Jespersen, AE; Obenhausen, K; Hafiz, P; Hestbæk, E; Gulyas, L; Kessing, LV; Bardram, JE, Internet-based cognitive assessment tool: Sensitivity and validity of a new online cognition screening tool for patients with bipolar disorder. J Affect Disord, 2021 vol. 289 pp. 125-134

Zarp Petersen, J; Varo, C; Skovsen, CF; Ott, CV; Kjaerstad, HL; Vieta, E; Harmer, CJ; Knudsen, GM; Kessing, LV; Macoveanu, J; Miskowiak, KW, Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study. Bipolar Disord, 2021.

Petersen JZ, Macoveanu J, Kjærstad HI, Knudsen GM, Kessing LV, Miskowiak KW, Assessment of the neuronal underpinnings of cognitive impairment in bipolar disorder with a picture encoding paradigm and methodological lessons learnt J Psychopharmacol. 2021 Aug.

Bjertrup AJ, Moszkowicz M, Egmose I, Kjærbye-Thygesen A, René E Nielsen RE, Parsons CE, Kessing LV, Pagsberg AK, Væver MS, Miskowiak KW Processing of infant emotion in mothers with mood disorders and implications for infant development Psychol Med. 2021 Apr 19;1-11

Jahn F.S., Skovbye M, Obenhausen K, Jespersen A.E., Miskowiak K., 

Ehrenreich H, Neubauer A-P, Miskowiak KW Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years JAMA. 2021;325(14):1470-1471

Miskowiak K., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M., Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables  European Neuropsychopharmacology 2021

Miskowiak K., Varo C., Social cognition in bipolar disorder: A proxy of psychosocial function and novel treatment target? European Neuropsychopharmacology 2021

Bjertrup A., Miskowiak K. Forstå dine hormoner under graviditet og efter fødsel engodstart.dk 2021

Bjertrup A., Miskowiak K. I risiko for fødselsdepression som mor? engodstart.dk 2021

Jensen M.B., Kjærstad H.L., Coello K., Stanislaus S., Melbye S., Sletved K. O., Vinberg M., Kessing L.V., Miskowiak K.W. Affective and non-affective cognition in patients with bipolar disorder type I and type II in full og partal remission: Associations with familial risk. J Affect Disord. 2021

Bjertrup A, Friis N, Væver M, Miskowiak K. Neurocognitive Processing of Infant Stimuli in Mothers and Non-Mothers: Psychophysiological, Cognitive and Neuroimaging Evidence. Soc Cogn Affect Neurosci. 2021 Jan 9:nsab002. doi: 10.1093/scan/nsab002. Epub ahead of print. PMID: 33420780. 

Ott et al. Norms for the Screen for Cognitive Impairment inPsychiatry and cognitive trajectories in bipolar disorder. J Affect Disord. 2021 Feb 15;281:33-40.

Hørlyck LD, Obenhausen K, Jansari A, Ullum H, Miskowiak KW. Virtual reality assessment of daily life executive functions in mood disorders: associations with neuropsychological and functional measures. J Affect Disord. 2020

Ott CV, Macoveanu J, Bowie CR, Fisher PM, Knudsen GM, Kessing LV, Miskowiak KW. Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trial. Neuropsychopharmacology. 2020 

Bjertrup AJ, Jensen MB, Schjødt MS, Parsons CE, Kjærbye-Thygesen A, Mikkelsen RL, Moszkowicz M, Frøkjær VG, Vinberg M, Kessing LV, Væver MS, Miskowiak KW. Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression. Eur Neuropsychopharmacol. 2020 

Miskowiak KW. Erythropoietin as possible treatment of brain diseases. Ugeskr Laeger. 2020

Ott CV, Vinberg M, Kessing LV, Bowie CR, Forman JL, Miskowiak KW. Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial. Bipolar Disord. 2020 

Seeberg I, Nielsen IB, Jørgensen CK, Eskestad ND, Miskowiak KW. Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review. J Affect Disord. 2020

Macoveanu J, Meluken I, Kessing LV, Siebner HR, Vinberg M, Miskowiak KW. Hippocampal subfield morphology in monozygotic twins discordant for affective disorders. Neuropsychopharmacology. 2020 

Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020

Ehrenreich H, Neubauer AP, Miskowiak K. Erythropoietin in Preterm Infants. N Engl J Med. 2020

Macoveanu J, Kjaerstad HL, Chase HW, Frangou S, Knudsen GM, Vinberg M, Kessing LV, Miskowiak KW. Abnormal prefrontal cortex processing of reward prediction errors in recently diagnosed patients with bipolar disorder and their unaffected relatives. Bipolar Disord. 2020

Petersen CS, Miskowiak KW. Toward a transdiagnostic neurocircuitry-based biomarker model for pro-cognitive effects: challenges, opportunities, and next steps. CNS Spectr. 2020

Macoveanu J, Meluken I, Chase HW, Phillips ML, Kessing LV, Siebner HR, Vinberg M, Miskowiak KW. Reduced frontostriatal response to expected value and reward prediction error in remitted monozygotic twins with mood disorders and their unaffected high-risk co-twins. Psychol Med. 2020

Kjærstad HL, Jørgensen CK, Broch-Due I, Kessing LV, Miskowiak K. Eye gaze and facial displays of emotion during emotional film clips in remitted patients with bipolar disorder. Eur Psychiatry. 2020

Miskowiak KW, Lewandowski KE. Trajectory of cognitive functions in bipolar disorder: for better or worse? Acta Psychiatr Scand. 2020 Feb;141(2):95-97. 

Miskowiak KW, Forman JL, Vinberg M, Siebner HR, Kessing LV, Macoveanu J. Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial. J Psychiatry Neurosci. 2020 May 1;45(3):198-205

Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Del Mar Bonnin C, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Van Rheenen TE, Vieta E. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disord. 2020;21(8):686-719. 

Vestergaard M, Kongerslev MT, Thomsen MS, Mathiesen BB, Harmer CJ, Simonsen E, Miskowiak KW. Women With Borderline Personality Disorder Show Reduced Identification of Emotional Facial Expressions and a Heightened Negativity Bias. J Pers Disord. 2020 Oct;34(5):677-698.

Meluken, I., Ottesen, N., Harmer, C., Macoveanu, J., Siebner, H., Kessing, L., ... & Miskowiak, K. (2019). Neural response to emotional faces in monozygotic twins: association with familial risk of affective disorders. Journal of psychiatry & neuroscience: JPN, 44(3), 1-10.

Ott, C. V., Johnson, C. B., Macoveanu, J., & Miskowiak, K. (2019). Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders: A systematic review. European Neuropsychopharmacology.

Petersen, J. Z., Porter, R. J., & Miskowiak, K. W. (2019). Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression. Journal of affective disorders, 246, 763-774.

Meluken, I., Ottesen, N. M., Phan, K. L., Goldin, P. R., Di Simplicio, M., Macoveanu, J., ... & Miskowiak, K. W. (2019). Neural response during emotion regulation in monozygotic twins at high familial risk of affective disorders. NeuroImage: Clinical, 21, 101598.

Ottesen, N. M., Meluken, I., Scheike, T., Kessing, L. V., Miskowiak, K. W., & Vinberg, M. (2018). Clinical characteristics, life adversities and personality traits in monozygotic twins with, at risk of and without affective disorders. Frontiers in psychiatry, 9.

Petersen, J. Z., Schmidt, L. S., Vinberg, M., Jørgensen, M. B., Hageman, I., Ehrenreich, H., Knudsen, G.M., Kessing, L.V., & Miskowiak, K. W. (2018). Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial. Trials, 19(1), 611.

Kessing, L. V., & Miskowiak, K. (2018). Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper. Frontiers in Psychiatry, 9.

Ottesen, N. M., Meluken, I., Scheike, T., Kessing, L. V., Miskowiak, K. W., & Vinberg, M. (2018). Clinical Characteristics, Life Adversities and Personality Traits in Monozygotic Twins With, at Risk of and Without Affective Disorders. Frontiers in psychiatry, 9.

Ott, C. V., Vinberg, M., Bowie, C. R., Christensen, E. M., Knudsen, G. M., Kessing, L. V., & Miskowiak, K. W. (2018). Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial. Trials, 19(1), 487.

Miskowiak, K. W., & Petersen, C. S. (2018). Neuronal underpinnings of cognitive impairment and-improvement in mood disorders. CNS spectrums, 1-24.

Seeberg, I., Kjærstad, H. L., & Miskowiak, K. (2018). Neural and behavioral predictors of treatment efficacy on mood symptoms and cognition in mood disorders: A systematic review. Frontiers in psychiatry, 9, 337.

Macoveanu, J., Demant, K. M., Vinberg, M., Siebner, H. R., Kessing, L. V., & Miskowiak, K. W. (2018). Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder. Journal of Psychopharmacology, 32(10), 1075-1085.

Meluken, I., Ottesen, N. M., Harmer, C. J., Scheike, T., Kessing, L. V., Vinberg, M., & Miskowiak, K. W. (2018). Is aberrant affective cognition an endophenotype for affective disorders?–A monozygotic twin study. Psychological medicine, 1-10.

Miskowiak, K. W., Macoveanu, J., Jørgensen, M. B., Ott, C. V., Støttrup, M. M., Jensen, H. M., ... & Kessing, L. V. (2018). Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study. European Neuropsychopharmacology.

Miskowiak, K. W., Petersen, N. A., Harmer, C. J., Ehrenreich, E., Kessing, L. V., Vinberg, M., ... & Siebner, H. R. (2018). Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder. Acta Psychiatrica Scandinavica, 138(4), 336-347.

Broch-Due, I., Kjærstad, H. L., Kessing, L. V., & Miskowiak, K. (2018). Subtle behavioural responses during negative emotion reactivity and down-regulation in bipolar disorder: A facial expression and eye-tracking study. Psychiatry research, 266, 152-159.

Petersen, J. Z., & Miskowiak, K. W. (2018). Cognitive side effects of electroconvulsive therapy. Ugeskrift for laeger, 180(18).

Miskowiak, K. W., Macoveanu, J., Jørgensen, M. B., Støttrup, M. M., Ott, C. V., Jensen, H. M., ... & Siebner, H. R. (2017). Neural response after a single ECT session during retrieval of emotional self-referent words in depression: a randomized, sham-controlled fMRI study. International Journal of Neuropsychopharmacology, 21(3), 226-235.

Schmidt, L. S., Petersen, J. Z., Vinberg, M., Hageman, I., Olsen, N. V., Kessing, L. V., ... & Miskowiak, K. W. (2018). Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial. Trials, 19(1), 234.

Kærsgaard, S., Meluken, I., Kessing, L. V., Vinberg, M., & Miskowiak, K. W. (2018). Increased sensitivity to positive social stimuli in monozygotic twins at risk of bipolar vs. unipolar disorder. Journal of affective disorders, 232, 212-218.

Miskowiak, K. W., Burdick, K. E., Martinez‐Aran, A., Bonnin, C. M., Bowie, C. R., Carvalho, A. F., ... & McIntyre, R. S. (2018). Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar disorders, 20(3), 184-194

Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Torres IJ, Yatham LN, Young AH, Kessing LV, Vieta E. (2017). Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Kjær KS, Hageman I, Wörtwein G, Jørgensen MB, Miskowiak KW. (2017). Erythropoietin treatment may improve cognition in neuropsychiatricdisorders.

Miskowiak KW, Larsen JE, Harmer CJ, Siebner HR, Kessing LV, Macoveanu J, Vinberg M. (2017). Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression.

Miskowiak KW, Kjaerstad HL, Støttrup MM, Svendsen AM, Demant KM, Hoeffding LK, Werge TM, Burdick KE, Domschke K, Carvalho AF, Vieta E, Vinberg M, Kessing LV, Siebner HR, Macoveanu J. (2017). The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.

Miskowiak KW, Svendsen AM, Harmer CJ, Elliott R, Macoveanu J, Siebner HR, Kessing LV, Vinberg M. (2017). Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression. Psychol Med.

Miskowiak KW, Kjaerstad HL, Støttrup MM, Svendsen AM, Demant KM, Hoeffding LK, Werge TM, Burdick KE, Domschke K, Carvalho AF, Vieta E, Vinberg M, Kessing LV, Siebner HR, Macoveanu J. (2017). The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. Bipolar Disord.

Elias, L. R., Miskowiak, K. W., Vale, A. M., Köhler, C. A., Kjærstad, H. L., Stubbs, B., ... & Carvalho, A. F. (2017). Cognitive Impairment in Euthymic Pediatric Bipolar Disorder: A Systematic Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry.

Miskowiak, K. W., Kessing, L. V., Ott, C. V., Macoveanu, J., Harmer, C. J., Jørgensen, A., ... & Jørgensen, M. B. (2017). Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study. Journal of Psychopharmacology.

Miskowiak KW (2016). Could EPO studies improve mood disorder treatment strategies? Expert Rev Neurother.

Miskowiak KW, Kjærstad HL, Meluken I, Petersen JZ, Maciel BR, Köhler CA, Vinberg M, Kessing LV, Carvalho AF (2016). The search for neuroimaging and cognitive endophenotypes: A criticial systematic review of studies involving unaffected first-degree relatives of individuals with bipolar disorder. Neurosci Biobehav Rev.

Miskowiak KW, Ott CV, Petersen JZ, Kessing LV (2016). Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field. Eur Neuropsychopharmacol.

Miskowiak KW, Petersen JZ, Ott CV, Knorr U, Kessing LV, Gallagher P, Robinson L (2016). Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: a novel methodology. Acta Psychiatr Scand.

Miskowiak KW, Carvalho AF, Vieta E, Kessing LV.​​ (2016). Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations. Eur Neuropsychopharmacol.​

Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW​. (2016). Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities. J Affect Disord.​​

Ott, C.V., Vinberg, M., Kessing, L.V., & Miskowiak, K.W. (2016). The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints​. European Neuropsychopharmacology.

Miskowiak, K.W., Macoveanu, J., Vinberg, M., Assentoft, E., Randers, L., Harmer, C.J., ... & Kessing, L.V. (2016). Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders​. Acta Psychiatrica Scandinavica.​

Vinberg M, Weikop P, Olsen NV, Kessing LV, Miskowiak K. (2016): Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study​, Brain, behavior, and immunity.

Miskowiak, K. W., Rush, J. A., Gerds, T. A., Vinberg, M., & Kessing, L. V. (2016). Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin. The Journal of clinical psychiatry, 77(12), e1639-e1646.

Miskowiak KW, Vinberg M, Glerup L, Paulson OB, Knudsen GM, Ehrenreich H, Harmer CJ, Kessing LV, Siebner HR, Macoveanu J (2016): Neural correlates of improved executive function following erythropoietin treatment in mood disorders, Psychological Medicine, 46(8), 1679-1691.

Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR (2015): Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders. Biological Psychiatry 78(4):270-7

Kjaerstad KH, Vinberg M, Goldin PR, Koester N, Stoettrup MM, Knorr U, Kessing LV, Miskowiak KW (2016): Impaired down-regulation of negative emotion in self-referent social situations in bipolar disorder: A pilot study of a novel experimental paradigm, Psychiatry Research (in press)

Ott CV, Bjertrup AJ, Jensen JH, Ullum H, Sjælland R, Purdon SE, Vieta E, Kessing LV, Miskowiak KW (2016): Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools, Journal of Affective Disorders 190:607-15

Jensen JH, Støttrup MM, Nayberg E, Knorr U, Ullum H, Purdon SE, Miskowiak KW (2015): Optimising screening for cognitive dysfunction in bipolar disorder: validation and evaluation of objective and subjective tools, Journal of Affective Disorders 187:10-19

Demant KM, Vinberg M, Kessing KV, Miskowiak KW (2015): Assessment of subjective and objective cognitive function in bipolar disorder: correlations, predictors and the relation to psychosocial function. Psychiatry Research 229(1-2):565-71

Demant KM, Vinberg M, Kessing KV, Miskowiak KW (2015): Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. PLoS One 10(6):e01279

Miskowiak KW, Glerup L, Vestbo C, Harmer CJ, Reinecke A, Macoveanu J, Siebner HR, Kessing LV, Vinberg M (2015): Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression. Psychological Medicine 45(7):1447-58

Vinberg M, Miskowiak KW, Jensen PH, Pedersen M, Kessing LV (2015):The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study. PLoS One 10(5):e0127629

Miskowiak KW, Ehrenreich H, Kessing LV, Vinberg M (2015): Dr Miskowiak and colleagues reply. Journal of Clinical Psychiatry 76(6):e835-6

Østergaard SD, Bech P, Miskowiak KW (2014): Fewer study participants needed to demonstrate superior antidepressant efficacy ​when using the Hamilton melancholia subscale (HAM-D6) as outcome measure. J Affect Disord (in press)

Miskowiak KW, Carvalho A (2014): 'Hot' cognition in depression: a systematic review. CNS & Neurological Disorders – Drug Targets 13(10):1787-803 [Impact Factor: 2.7]

Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M (2014): Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: A double-blind, randomized, placebo-controlled phase 2 trial. Journal of Clinical Psychiatry 75(12):1347-55

Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, Kessing LV (2014): Recombinant human erythropoietin for treating treatment-resistant depression: A double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology 39(6):1399-1408

Demant KM, Almer GM, Vinberg M, Kessing LV, Miskowiak KW (2013):Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial. Trials14(1):378

Svendsen AM, Miskowiak K, Vinberg M (2013): Risk of long-lasting negative cognitive consequences after electroconvulsive therapy. Danish Medical Journal 175(44):2649-2650

Vinberg M, Miskowiak KW, Kessing LV (2013): Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins. Journal of Clinical Psychiatry 74(8):747-53

Vinberg M, Miskowiak K, Kessing LV (2013): Risk markers for affective disorder, a seven-years follow up study of a twin cohort at low and high risk for affective disorder. Journal of Psychiatric Research 47: 565–71

Miskowiak KW, Vinberg M, Harmer CJ, Ehrenreich H, Kessing LV (2012): Erythropoietin – a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berlin) 219(3):687-98 [Impact Factor: 3.9]

Svendsen AM, Vinberg M, Munkholm K, Kessing LV, Miskowiak KW (2012): Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?Nordic Journal of Psychiatry 66:248-53

Miskowiak KW, Vinberg M, Christensen EM, Kessing KV (2012): Is there a difference in subjective experience of cognitive function in patients with unipolar disorder versus bipolar disorder? Nordic Journal of Psychiatry ​66(6):389-39

Miskowiak KW, Vinberg M, Harmer CJ, Ehrenreich H, Knudsen GM, Macoveanu J, et al. (2010): Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 11: 97​

Miskowiak KW & Kessing LV (2016): Cognitive enhancement in bipolar disorder: current evidence and methodological considerations, chapter 23 in 'The Treatment of Bipolar Disorder: Integrative treatment strategies and Future Directions', edited by Carvalho C & Vieta E, Oxford University Press.

Miskowiak KW (2015): A novel treatment for cognitive dysfunction in mood disorders, chapter 21 in 'Cognitive Dysfunction in Major Depressive Disorder', edited by McIntyre R & Cha D, Cambridge University Press.​​​